ATE205089T1 - Verwendung von einem cgrp antagonist für die behandlung von augen oder augenlidpruritus und dysesthesien - Google Patents
Verwendung von einem cgrp antagonist für die behandlung von augen oder augenlidpruritus und dysesthesienInfo
- Publication number
- ATE205089T1 ATE205089T1 AT96400459T AT96400459T ATE205089T1 AT E205089 T1 ATE205089 T1 AT E205089T1 AT 96400459 T AT96400459 T AT 96400459T AT 96400459 T AT96400459 T AT 96400459T AT E205089 T1 ATE205089 T1 AT E205089T1
- Authority
- AT
- Austria
- Prior art keywords
- priritus
- dysesthesia
- eyelid
- eye
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/225—Calcitonin gene related peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9503629A FR2732222B1 (fr) | 1995-03-28 | 1995-03-28 | Utilisation d'un antagoniste de cgrp pour le traitement des prurits et des dysesthesies oculaires et palpebraux |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE205089T1 true ATE205089T1 (de) | 2001-09-15 |
Family
ID=9477499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96400459T ATE205089T1 (de) | 1995-03-28 | 1996-03-04 | Verwendung von einem cgrp antagonist für die behandlung von augen oder augenlidpruritus und dysesthesien |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6169069B1 (de) |
| EP (1) | EP0734730B1 (de) |
| JP (1) | JP3024064B2 (de) |
| AR (1) | AR002975A1 (de) |
| AT (1) | ATE205089T1 (de) |
| BR (1) | BR9601461A (de) |
| CA (1) | CA2172779C (de) |
| DE (1) | DE69614907T2 (de) |
| DK (1) | DK0734730T3 (de) |
| ES (1) | ES2163596T3 (de) |
| FR (1) | FR2732222B1 (de) |
| HU (1) | HUP9600766A3 (de) |
| MX (1) | MX9601149A (de) |
| PL (1) | PL313513A1 (de) |
| RU (1) | RU2155601C2 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7081241B1 (en) * | 1998-10-06 | 2006-07-25 | The Trustees Of Columbia University In The City Of New York | Extracellular rage binding protein (EN-RAGE) and uses thereof |
| US7112334B2 (en) * | 2001-06-05 | 2006-09-26 | Freiberg Roberta C | Allergy inhibition |
| US20040038861A1 (en) * | 2001-11-26 | 2004-02-26 | Cooper Garth J. S. | Methods and compositions for normalizing lipid levels in mammalian tissues |
| US8168592B2 (en) * | 2005-10-21 | 2012-05-01 | Amgen Inc. | CGRP peptide antagonists and conjugates |
| EP3069731A1 (de) | 2005-11-14 | 2016-09-21 | Labrys Biologics Inc. | Antagonistische antikörper gegen calcitoningen-assoziiertes peptid und verfahren damit |
| RU2522493C2 (ru) | 2008-03-04 | 2014-07-20 | Пфайзер Лимитед | Способы лечения хронической боли |
| US8623366B2 (en) | 2009-08-28 | 2014-01-07 | Labrys Biologics, Inc. | Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide |
| CU24163B1 (es) * | 2011-06-28 | 2016-03-31 | Bayer Healthcare Llc | Composición farmacéutica oftalmológica tópica que contiene regorafenib |
| EP3089748A4 (de) | 2014-01-02 | 2017-09-27 | Massachusetts Eye & Ear Infirmary | Behandlung von neovaskularisierung im auge |
| CN106456759A (zh) | 2014-03-21 | 2017-02-22 | 泰华制药国际有限公司 | 针对降钙素基因相关肽的拮抗剂抗体及其使用方法 |
| US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| CN109952314A (zh) | 2016-09-23 | 2019-06-28 | 泰瓦制药国际有限公司 | 治疗难治性偏头痛 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9201425D0 (sv) * | 1992-05-06 | 1992-05-06 | Kabi Pharmacia Ab | Method and means for preventing constriction of the pupil in the eye |
-
1995
- 1995-03-28 FR FR9503629A patent/FR2732222B1/fr not_active Expired - Fee Related
-
1996
- 1996-03-04 DK DK96400459T patent/DK0734730T3/da active
- 1996-03-04 EP EP96400459A patent/EP0734730B1/de not_active Expired - Lifetime
- 1996-03-04 ES ES96400459T patent/ES2163596T3/es not_active Expired - Lifetime
- 1996-03-04 AT AT96400459T patent/ATE205089T1/de active
- 1996-03-04 DE DE69614907T patent/DE69614907T2/de not_active Expired - Lifetime
- 1996-03-25 BR BR9601461A patent/BR9601461A/pt not_active Application Discontinuation
- 1996-03-27 CA CA002172779A patent/CA2172779C/fr not_active Expired - Fee Related
- 1996-03-27 HU HU9600766A patent/HUP9600766A3/hu unknown
- 1996-03-27 RU RU96105819/14A patent/RU2155601C2/ru not_active IP Right Cessation
- 1996-03-27 MX MX9601149A patent/MX9601149A/es not_active IP Right Cessation
- 1996-03-27 JP JP8072774A patent/JP3024064B2/ja not_active Expired - Fee Related
- 1996-03-27 AR AR10192996A patent/AR002975A1/es unknown
- 1996-03-27 PL PL96313513A patent/PL313513A1/xx unknown
- 1996-03-28 US US08/623,576 patent/US6169069B1/en not_active Expired - Fee Related
-
2000
- 2000-06-08 US US09/589,117 patent/US6344438B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2163596T3 (es) | 2002-02-01 |
| US6344438B1 (en) | 2002-02-05 |
| EP0734730B1 (de) | 2001-09-05 |
| AR002975A1 (es) | 1998-05-27 |
| BR9601461A (pt) | 1998-03-31 |
| DE69614907D1 (de) | 2001-10-11 |
| DE69614907T2 (de) | 2002-01-17 |
| RU2155601C2 (ru) | 2000-09-10 |
| JPH08268913A (ja) | 1996-10-15 |
| CA2172779A1 (fr) | 1996-09-29 |
| PL313513A1 (en) | 1996-09-30 |
| HUP9600766A2 (en) | 1997-06-30 |
| CA2172779C (fr) | 2001-12-25 |
| FR2732222B1 (fr) | 1997-04-25 |
| US6169069B1 (en) | 2001-01-02 |
| HU9600766D0 (en) | 1996-05-28 |
| HUP9600766A3 (en) | 1998-04-28 |
| EP0734730A1 (de) | 1996-10-02 |
| FR2732222A1 (fr) | 1996-10-04 |
| MX9601149A (es) | 1997-08-30 |
| JP3024064B2 (ja) | 2000-03-21 |
| DK0734730T3 (da) | 2001-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE168011T1 (de) | Verwendung von einem cgrp antagonist für dir behandlung von hauterythemen neurogenischen ursprung und erhaltene zubearbeitung | |
| DE69318501D1 (de) | Augenuntersuchungs- und/oder Behandlungsinstrument | |
| ATE205089T1 (de) | Verwendung von einem cgrp antagonist für die behandlung von augen oder augenlidpruritus und dysesthesien | |
| DE59608738D1 (de) | Verwendung von epinastin für die behandlung von schmerzen | |
| DE69024039T2 (de) | Behandlung von pathologischen zuständen und krankheiten. | |
| DE69629438D1 (de) | Mischungen von absorbierbaren Polyoxaestern die Amin und/oder Amido-Gruppen enthalten | |
| ATE229502T1 (de) | Arylsulfonamide und analoga und ihre verwendung zur behandlung von neurodegenerativen erkrankungen | |
| ATE331522T1 (de) | Zusammensetzung zur behandlung von atemwegs- und hauterkrankungen mit mindestens einem leukotrienantagonist und mindestens einem antihistaminikum | |
| FI990268A (fi) | Ei-peptidi-NK-antagonistin käytt¦ ihosairauksien ja kutinan hoitoon tarkoitettujen lääkkeiden valmistukseen | |
| ATE178487T1 (de) | Verwendung von 2-amino-4-(4-fluorbenzylamino)-1- ethoxycarbonylaminobenzen zur prophylaxe und behandlung der folgen der akuten und chronischen zerebralen minderdurchblutung sowie neurodegenerativer erkrankungen | |
| DE69432299D1 (de) | Multiple Botulinum Toxine zur Behandlung von neuromuskulären Störungen und Zuständen | |
| DE59603216D1 (de) | Esterquats und ihre Verwendung zur Herstellung von oberflächenaktiven Mitteln, insbesondere zur Haar- und Körperpflege | |
| ATA11989A (de) | Mittel zur vorbeugung gegen und behandlung von parodontopathien | |
| DE69429923D1 (de) | Verwendung von acrylblockcopolymere als netzmittel und/oder dispergiermittel für feststoffteilchen und die daraus hergestellten dispersionen | |
| FR2647675B1 (fr) | Utilisation d'un derive de la statine dans le traitement des affections oculaires | |
| DE69635708D1 (de) | Tetrandrin zur behandlung von augenentzündungen | |
| DE69412262D1 (de) | Die Verwendung von Fluoroelastomer-freundlichen Kurbelgehäuse- und Antrieb-Schmiermitteln | |
| DE69331105T2 (de) | Verwendung von thioureleyne und thiabendazol in auto immunbedingten und entzündlichen hauterkrankungen | |
| ATE221763T1 (de) | Die verwendung von glyceryltriacetat zur behandlung von onychomykosen | |
| DE69031122T2 (de) | Verfahren und vorrichtung für die behandlung und verhinderung von rückgrathaltungsmängeln | |
| DE69613041D1 (de) | Verwendung von Erdalkalimetalsalzen in Mitteln zur Behandlung van Augen- oder Augenlidschmerzen oder Dysesthesien | |
| ATE201828T1 (de) | Verwendung eines cgrp antagonisten zur behandlung von flechten und pruritus und so erhaltene zubereitung | |
| DE59806627D1 (de) | Arylsulfonamide und analoga und ihre verwendung zur behandlung von neurodegenerativen erkrankungen | |
| DE69319127D1 (de) | Konjugat für den Nachweis und/oder Quantifizierung von biologischen Komponenten | |
| DE69531794D1 (de) | Verwendung der Heterodimere S2/S4 und/oder S3/S4 des B-Oligomers des Pertussis Toxins bei der Behandlung von Autoimmunkrankheiten. |